Abstracts tagged "big data and diagnostic criteria"

Abstract Number: 634 • 2015 ACR/ARHP Annual Meeting
Big Data International Primary Sjögren Syndrome Registry: Baseline Characterization and Diagnostic Approach in 6047 Patients Fulfilling the 2002 AE Criteria
Pilar Brito-Zerón¹, Soledad Retamozo^1,2, Margit Zeher³, Astrid Rasmussen⁴, Elke Theander⁵, Jacques Gottenberg⁶, Chiara Baldini⁷, Luca Quartuccio⁸, Roberta Priori⁹, Valeria Valim¹⁰, Marika Kvarnström¹¹, Aike Kruize¹², Gabriela Hernandez-Molina¹³, Elena Bartoloni-Bocci¹⁴, Sonja Praprotnik¹⁵, David A. Isenberg¹⁶, Gunnel Nordmark¹⁷, Michele Bombardieri¹⁸, Yasunori Suzuki¹⁹, Roser Solans²⁰, Roberto Giacomelli²¹, Daniel S. Hammenfors²², Steven E. Carsons²³, Hendrika Boostma²⁴, Cristina F. Vollenweider²⁵, Fabiola Atzeni²⁶, Kathy Sivils²⁷, Thomas Mandl²⁸, Salvatore De Vita²⁹, Marie Wahren-Herlenius¹¹, Mitsuhiro Kawano³⁰, Roberto Gerli³¹, Arjan Vissink³², Johan G. Brun³³, Virginia Trevisani³⁴, Jorge Sánchez-Guerrero³⁵, Xavier Mariette³⁶, Manuel Ramos-Casals¹ and on behalf of the EULAR-SS Task Force, ¹Department of Autoimmune Diseases, CELLEX-IDIBAPS, Hospital Clínic, Barcelona, Barcelona, Spain, ²Rheumatology Unit, Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina, ³University of Debrecen, Debrecen, Hungary, ⁴Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, ⁵Skåne University Hospital Malmö, Lund University, Malmo, Sweden, ⁶Hôpitaux Universitaires de Strasbourg, Strasbourg, France, ⁷Rheumatology Unit, University of Pisa, Italy, Pisa, Italy, ⁸Clinic of Rheumatology, Department of Medical and Biological Sciences (DSMB), Santa Maria della Misericordia Hospital, University of Udine, Udine, Italy, ⁹Rheumatology Unit, Sapienza University of Rome, Rome, Italy, ¹⁰Rheumatology, Universidade Federal do Espírito Santo, Vitória, Brazil, ¹¹Department of medicine, Rheumatology unit, Karolinska Institutet, Stockholm, Sweden, ¹²Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, ¹³Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico city, Mexico, ¹⁴Department of Medicine, Rheumatology Unit, University of Perugia, Perugia, Italy, ¹⁵Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, ¹⁶Rayne Institute, Centre for Rheumatology Research, UCL Division of Medicine, London, United Kingdom, ¹⁷Medical Sciences, Uppsala University, Uppsala, Sweden, ¹⁸Experimental Medicine and Rheumatology, Queen Mary University of London, London, United Kingdom, ¹⁹Kanazawa University Graduate School of Medicine, Kanazawa, Japan, ²⁰Department of Internal Medicine, Hospital Vall d'Hebron, Barcelona, Spain, ²¹University of L'Aquila, L'Aquila, Italy, ²²Department of Rheumatology, Haukeland University Hospital, Bergen, Norway, ²³Rheumatology, Allergy and Immunology, Winthrop University Hospital, Mineola, NY, ²⁴University of Groningen, University Medical Center Groningen, Groningen, Netherlands, ²⁵Rheumatology, German Hospital, Buenos Aires, Argentina, ²⁶Rheumatology Unit, L. Sacco University Hospital of Milan, Milan, Italy, ²⁷Oklahoma Medical Research Foundation, Oklahoma City, OK, ²⁸Dept of Rheumatology, Skåne University Hospital Malmö, Lund University, Malmo, Sweden, ²⁹Santa Maria della Misericordia Hospital, University of Udine, Udine, Italy, ³⁰Division of Rheumatology, Kanazawa University Graduate School of Medicine, Kanazawa, Japan, ³¹University of Perugia, Perugia, Italy, ³²Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, ³³Haukeland University Hospital, Bergen, Norway, ³⁴Health Evidence Based, Universidade Federal de São Paulo, Sâo Paulo, Brazil, ³⁵Rheumatology, Mount Sinai Hospital and University Health Network, Toronto Canada, Toronto, ON, Canada, ³⁶Université Paris-Sud, AP-HP, Hôpitaux Universitaires Paris-Sud, Paris, France
Background/Purpose: To analyse the epidemiological, clinical and immunological characteristics at diagnosis of the largest international cohort of patients diagnosed with primary Sjögren syndrome (SS) according…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].